Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes
- PMID: 30149455
- PMCID: PMC8565654
- DOI: 10.3233/JAD-180570
Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes
Abstract
Background: Alzheimer's disease (AD) and type 2 diabetes (T2DM) are common causes of cognitive decline among older adults and share strong epidemiological links. Distinct patterns of cortical atrophy are observed in AD and T2DM, but robust comparisons between structure-function relationships across these two disease states are lacking.
Objective: To compare how atrophy within distributed brain networks is related to cognition across the spectrum of cognitive aging.
Methods: The relationship between structural MRI changes and cognition was studied in 22 mild-to-moderate AD, 28 T2DM, and 27 healthy participants. Cortical thickness measurements were obtained from networks of interest (NOIs) matching the limbic, default, and frontoparietal resting-state networks. Composite cognitive scores capturing domains of global cognition, memory, and executive function were created. Associations between cognitive scores and the NOIs were assessed using linear regression, with age as a covariate. Within-network General Linear Model (GLM) analysis was run in Freesurfer 6.0 to visualize differences in patterns of cortical atrophy related to cognitive function in each group. A secondary analysis examined hemispheric differences in each group.
Results: Across all groups, cortical atrophy within the limbic NOI was significantly correlated with Global Cognition (p = 0.009) and Memory Composite (p = 0.002). Within-network GLM analysis and hemispheric analysis revealed qualitatively different patterns of atrophy contributing to cognitive dysfunction between AD and T2DM.
Conclusion: Brain network atrophy is related to cognitive function across AD, T2DM, and healthy participants. Differences in cortical atrophy patterns were seen between AD and T2DM, highlighting neuropathological differences.
Keywords: Alzheimer’s disease; cognitive aging; dementia; diabetes mellitus; executive function; memory disorders.
Figures

References
-
- National Institute on Aging (2007) Why Population Aging Matters: A Global Perspective. https://www.nia.nih.gov/sites/default/files/2017-06/WPAM.pdf
-
- Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12, 207–216. - PMC - PubMed
-
- Han S-H, Lee M-A, An SS, Ahn S-W, Youn YC, Park K-Y (2014) Diagnostic value of Alzheimer’s disease-related individual structural volume measurements using IBASPM. J Clin Neurosci 21, 2165–2169. - PubMed
-
- Burton EJ, Barber R, Mukaetova-Ladinska EB, Robson J, Perry RH, Jaros E, Kalaria RN, O’Brien JT (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis. Brain 132, 195–203. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical